Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 1: Discovery and SAR study of 4-pyrazolylpiperidine side chains

This publication has 21 references indexed in Scilit:

• Piperazine-Based CCR5 Antagonists as HIV-1 Inhibitors. II. Discovery of 1-[(2,4-Dimethyl-3-pyridinyl)carbonyl]-4- methyl-4-[3(S)-methyl-4-[1(S)-[4-(trifluoro- methyl)phenyl]ethyl]-1-piperazinyl]- piperidine N1-Oxide (Sch-350634), an Orally Bioavailable, Potent CCR5 Antagonist
  Journal of Medicinal Chemistry, 2001
• Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 4: synthesis and structure–Activity relationships for 1-[N-(Methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-(4-(N-(alkyl)-N-(benzyloxycarbonyl)amino)piperidin-1-yl)butanes
  Bioorganic & Medicinal Chemistry Letters, 2001
• Small molecule antagonists of chemokine receptors as emerging anti-HIV agents
  Expert Opinion on Therapeutic Patents, 2001
• Co‐receptor use by HIV and inhibition of HIV infection by chemokine receptor ligands
  Immunological Reviews, 2000
• The chemokine/chemokine-receptor family: potential and progress for therapeutic intervention
  Current Opinion in Chemical Biology, 2000
• HIV-1 entry – an expanding portal for drug discovery
  Drug Discovery Today, 2000
• CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis
  Immunogenetics, 2000
• Chemokine Receptor Antagonists
  Medicinal Research Reviews, 2000
• A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity
  Proceedings of the National Academy of Sciences, 1999
• Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection
  Cell, 1996